LobbyingGeisinger Health lobbying by quarter
Geisinger Health's latest lobbying report covers Q2 2026, at $130K. The four quarters Q4 2025–Q3 2026 total $343.4K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Geisinger Health
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $343.4K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $164.6K | 1 |
| Q1 2023 | $72.4K | 1 |
| Q2 2023 | $67.7K | 1 |
| Q3 2023 | $30.4K | 1 |
| Q4 2023 | $46.1K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $70K | 1 |
| Q3 2024 | $70K | 1 |
| Q4 2024 | $66.8K | 1 |
| Q1 2025 | $90.5K | 1 |
| Q2 2025 | $99.5K | 1 |
| Q3 2025 | $90K | 1 |
| Q4 2025 | $105.2K | 1 |
| Q1 2026 | $108.2K | 1 |
| Q2 2026 | $130K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1M · 11 reports
- Medicare and Medicaid$121.1K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES13 reports
- SENATE12 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseGeisinger Health | $1.3M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHRISTOPHER BECK | Staff Assistant, Former Sen. Arlen Specter | Q2 2026 |
| MARK REISINGER | Mark L. Reisinger | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $130K |
| 06/15for Q1 2024 | In-house | $60K |
| 06/15for Q2 2024 | In-house | $70K |
| 06/15for Q3 2024 | In-house | $70K |
| 04/20for Q1 | In-house | $108.2K |
| 01/20for Q4 2025 | In-house | $105.2K |
| 25/12/31for Q3 2025 | In-house | $90K |
| 25/10/20for Q3 2025 | In-house | $90K |
| 25/07/21for Q2 2025 | In-house | $99.5K |
| 25/04/20for Q1 2025 | In-house | $90.5K |
| 25/01/20for Q4 2024 | In-house | $66.8K |
| 24/10/18for Q3 2024 | In-house | $66.8K |
| 24/07/20for Q2 2024 | In-house | $66.6K |
| 24/04/18for Q1 2024 | In-house | $62.1K |
| 24/01/18for Q4 2023 | In-house | $46.1K |
| 23/10/19for Q3 2023 | In-house | $30.4K |
| 23/10/19for Q3 2023 | In-house | $30.4K |
| 23/10/19for Q3 2023 | In-house | $30.4K |
| 23/07/19for Q2 2023 | In-house | $67.7K |
| 23/04/20for Q1 2023 | In-house | $72.4K |